Dyne therapeutics market cap

WebApr 11, 2024 · Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Rating) have earned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. ... The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. The business has a 50 day … WebMar 17, 2024 · Dyne Therapeutics stock opened at $12.85 on Friday. Dyne Therapeutics has a 52 week low of $4.30 and a 52 week high of $15.63. The firm has a market cap of …

Dyne Therapeutics, Inc. (DYN) Stock Price Today, Quote & News

WebDyne Therapeutics, Inc. Analyst Report: Xcel Energy Inc. Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Discover historical prices for DYN stock on Yahoo Finance. View daily, weekly or … Get the detailed quarterly/annual income statement for Dyne Therapeutics, Inc. … View the basic DYN option chain and compare options of Dyne Therapeutics, … Find out the direct holders, institutional holders and mutual fund holders for … Dyne Therapeutics, Inc. 1560 Trapelo Road Waltham, MA 02451 United States 781 … See Dyne Therapeutics, Inc. (DYN) stock analyst estimates, including earnings … Find out all the key statistics for Dyne Therapeutics, Inc. (DYN), including … Dyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, … See Dyne Therapeutics, Inc. (DYN) Environment, Social and Governance … Find the latest Dyne Therapeutics, Inc. (DYN) stock quote, history, news and … WebYou can buy and sell Dyne Therapeutics (DYN) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. ... Market cap. 628.17M. Market cap 628.17M. Price-Earnings ratio-3.44. incarnation private school https://pacificasc.org

Dyne Therapeutics Inc

WebView the latest Dyne Therapeutics Inc. (DYN) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebFeb 28, 2024 · Latest Dyne Therapeutics Inc Stock News. As of February 28, 2024, Dyne Therapeutics Inc had a $681.8 million market capitalization, putting it in the 59th percentile of companies in the Biotechnology & Medical Research industry. Dyne Therapeutics Inc does not have a meaningful P/E due to negative earnings over the last … WebMar 23, 2024 · DYN Complete Dyne Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ... Market Cap $646.76M; Shares Outstanding … in commentary\u0027s

Is Dyne Therapeutics Inc (DYN) Stock a Good Investment? AAII

Category:Is Dyne Therapeutics Inc (DYN) Stock a Good Investment? AAII

Tags:Dyne therapeutics market cap

Dyne therapeutics market cap

Dyne Therapeutics Inc. Company & People DYN Barron

WebDyne Therapeutics (DYN) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... WebDyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle ...

Dyne therapeutics market cap

Did you know?

WebInformation on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. ... Market Cap Shares Average Volume EPS; $9.38: $9.11: $4.30 - $15.63 ... WebApr 6, 2024 · 91,5%. More Financials. Company. Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases.

WebApr 12, 2024 · Market Cap Chart Since the IPO on September 17, 2024, Dyne Therapeutics, Inc.'s market cap has decreased from $790.90M to $480.56M, a decrease of -39.24%. That is a compound annual growth rate of -17.66%. WebJan 27, 2024 · With a market capitalization of US$963m, Dyne Therapeutics is a decent size, so it is probably on the radar of institutional investors. In the chart below, we can see that institutions own shares ...

WebApr 10, 2024 · 5 brokerages have issued twelve-month target prices for Dyne Therapeutics' shares. Their DYN share price forecasts range from $18.00 to $34.00. On average, they … WebApr 11, 2024 · Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven …

WebJan 18, 2024 · Dyne Therapeutics had its IPO a year ago. The clinical-stage biotech has $407.5 million in cash but no revenue. The company specializes in treating serious …

WebApr 10, 2024 · Dyne Therapeutics Inc. company and executive profile by Barron's. View the latest DYN company infomation and executive bios. in commentary\\u0027sWebApr 7, 2024 · See the latest Dyne Therapeutics Inc Ordinary Shares stock price (NASDAQ:DYN), related news, valuation, dividends and more to help you make your … in command prompt change to c drivein command\\u0027sWebFounded. 2024. Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. in command windowWebReal time Dyne Therapeutics (DYN) stock price quote, stock graph, news & analysis. in command\u0027sWeb19 hours ago · Find the latest Price To Free Cash Flow for Dyne Therapeutics (DYN) ... Large-Cap Trader; ... 03/23/23-11:00AM EST Market News Video Dyne Therapeutics Receives FDA Orphan Drug and Rare Pediatric ... in commerce 49cfrWebComplete Dyne Therapeutics Inc. stock information by Barron's. View real-time DYN stock price and news, along with industry-best analysis. ... Market Cap. Vertex Pharmaceuticals Inc.-1.62 % $76 ... in command with global connect